ARMS™ allele-specific amplification-based detection of mutant p53 DNA and mRNA in tumors of the breast

Clinical Chemistry

Volumn 47, Issue 4, 2001, Pages 774-778

  Hodgson, D R ^a   Clayton, S J ^a   Girdler, F ^a   Brotherick, I ^a   Shenton, B ^a   Browell, D ^a   Stuart, M ^a   Fox, J C ^a   Ceuppens, P ^a   Foy, C A ^a   Whitcombe, D ^a   Gibson, N J ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; DNA; RNA; TUMOR MARKER;

ALLELE; ARTICLE; BLOOD SAMPLING; BREAST TUMOR; CANCER PATIENT; GENE AMPLIFICATION; IMMUNOHISTOCHEMISTRY; MESSENGER RNA SYNTHESIS; MUTANT; TUMOR VOLUME; BLOOD; CHEMISTRY; FEMALE; GENETICS; HUMAN; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BREAST NEOPLASMS; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; FEMALE; HUMANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0034744742     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/47.4.774     Document Type: Article

References (26)

1. Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis
2. Prognostic value of the immunohistochemical expression of p53 in breast carcinomas A review of the literature involving over 9000 patients
3. p53 mutations, methylation and genomic instability in the progression of chronic myeloid leukaemia
4. p53 protein accumulation and response to adjuvant chemotherapy in premenopausal women With node-negative early breast cancer
5. p53 exon 7 mutations as a predictor of poor prognosis in patients with colorectal cancer
6. The establishment of a preoperative diagnosis of pancreatic carcinoma using cell specimens from pancreatic duct brushing with special attention to p53 mutations
7. Predicting response to cancer chemotherapy: The role of p53
8. Can p53 help select patients with invasive bladder cancer for bladder preservation?
9. Meeting Highlights: International consensus panel on the treatment of primary breast cancer
10. Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients
11. Mutations in residues of TP53 that directly contact DNA predict poor outcome in human primary breast cancer
12. Predicting response to adjuvant and radiation therapy in patients with early stage breast carcinoma
13. Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS)
14. Analysis of the amplification refractory mutation allele-specific polymerase chain reaction system for sensitive and specific detection of p53 mutations in DNA
15. Detection of PCR products using self-probing amplicons and fluorescence
16. K-ras point mutation detection in lung cancer: Comparison of two approaches to somatic mutation detection using ARMS allele-specific amplification
17. Development, multiplexing, and application of ARMS tests for common mutations in the CFTR gene
18. A general method of in vitro preparation and specific mutagenesis of DNA fragments: A study of protein and DNA interactions
19. Biometry
20. Analysis of heterogeneous viral populations by direct DNA sequencing
21. Limitations of CD44v6 amplification for the detection of tumour cells in the blood of colorectal cancer patients
22. Detection of mutations and polymorphisms in the p53 tumor suppressor gene by single-strand conformation polymorphism analysis
23. Routine analysis of p53 mutation in clinical breast tumour specimens using fluorescence-based polymerase chain reaction and single strand conformation polymorphism
24. A simple p53 functional assay for screening cell lines, blood, and tumors
25. Assessment of sequence-based p53 gene analysis in human breast cancer: Messenger RNA in comparison with genomic DNA targets